BAKER BROS. ADVISORS LP 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:19 pm Sale | 2025-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 5,604,483 8.900% | -793,882 (-12.41%) | Filing |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,398,365 10.800% | 43,757 (+0.69%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,354,608 11.300% | 291,906 (+4.81%) | Filing |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,062,702 10.900% | 2,199,463 (+56.93%) | Filing |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 3,863,239 7.700% | 1,548,366 (+66.89%) | Filing |
| 2021-02-16 5:04 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 2,314,873 5.200% | -393,327 (-14.52%) | Filing |